Spots Global Cancer Trial Database for anal carcinoma
Every month we try and update this database with for anal carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer | NCT05438836 | Anal Cancer Anal Carcinoma Anal Squamous C... | online adaptive... | 18 Years - | Herlev Hospital | |
| Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer | NCT05438836 | Anal Cancer Anal Carcinoma Anal Squamous C... | online adaptive... | 18 Years - | Herlev Hospital | |
| Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | NCT02408861 | Advanced Malign... Anal Carcinoma HIV Infection Kaposi Sarcoma Lung Carcinoma Metastatic Mali... Recurrent Class... Refractory Clas... Unresectable So... | Biospecimen Col... Bone Marrow Bio... Computed Tomogr... Ipilimumab Nivolumab Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | NCT02369939 | Anal Carcinoma | Irradiation Mitomycin C 5-Fluorouracil Hyperthermia | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy | NCT04713618 | Anal Carcinoma Cervical Carcin... Endometrial Car... Malignant Pelvi... Rectal Carcinom... Vaginal Carcino... Vulvar Carcinom... | Pelvic Examinat... Survey | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | NCT02369939 | Anal Carcinoma | Irradiation Mitomycin C 5-Fluorouracil Hyperthermia | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor? | NCT03469596 | Anal Carcinoma | MRI sequence | 18 Years - | Fondation Hôpital Saint-Joseph | |
| Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group | NCT04230759 | Anal Cancer Anal Carcinoma Anal Cancer Sta... Anal Cancer Sta... | Chemotherapy Radiation Durvalumab | 18 Years - | Goethe University | |
| Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor? | NCT03469596 | Anal Carcinoma | MRI sequence | 18 Years - | Fondation Hôpital Saint-Joseph | |
| Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group | NCT04230759 | Anal Cancer Anal Carcinoma Anal Cancer Sta... Anal Cancer Sta... | Chemotherapy Radiation Durvalumab | 18 Years - | Goethe University | |
| Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | NCT02369939 | Anal Carcinoma | Irradiation Mitomycin C 5-Fluorouracil Hyperthermia | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | NCT02628067 | Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc... | pembrolizumab pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | NCT02628067 | Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc... | pembrolizumab pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III) | NCT03241680 | Anal Carcinoma Anal Condyloma | Search of anal ... | 18 Years - 65 Years | Universidade do Vale do Sapucai | |
| Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group | NCT04230759 | Anal Cancer Anal Carcinoma Anal Cancer Sta... Anal Cancer Sta... | Chemotherapy Radiation Durvalumab | 18 Years - | Goethe University | |
| Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III) | NCT03241680 | Anal Carcinoma Anal Condyloma | Search of anal ... | 18 Years - 65 Years | Universidade do Vale do Sapucai | |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | NCT02628067 | Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc... | pembrolizumab pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer | NCT04505553 | Appendix Carcin... Colon Carcinoma Esophageal Carc... Gastric Carcino... Liver and Intra... Malignant Diges... Pancreatic Carc... Rectal Carcinom... Small Intestina... Anal Carcinoma Digestive Syste... Digestive Syste... Pancreatic Neur... | Acupuncture The... Acupressure The... Oral Cryotherap... Questionnaire A... Quality-of-Life... | 18 Years - | University of Washington | |
| HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor | NCT05787535 | Cervical Cancer Head and Neck S... Oropharyngeal C... Vagina Tumor Carcinoma of Pe... Anal Carcinoma Carcinoma of Vu... | Fludarabine + C... HRYZ-T101 TCR-T... | 18 Years - 70 Years | HRYZ Biotech Co. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
